Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Arthritis Research & Therapy|January 24, 2020
Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality registerGiovanni Cagnotto, Minna Willim, Jan-Åke Nilsson, et al.
Annals of the Rheumatic Diseases|March 25, 2017
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-upVivek Anand Manivel, Mohammed Mullazehi, Leonid Padyukov, et al.
RMD Open|April 15, 2025
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesityLiselotte Tidblad, Anton Öberg Sysojev, Bénédicte Delcoigne, et al.
Arthritis and Rheumatism|September 24, 2010
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohortsSaedis Saevarsdottir, Sara Wedrén, Maria Seddighzadeh, et al.
Annals of the Rheumatic Diseases|April 8, 2014
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trialSaedis Saevarsdottir, Hamed Rezaei, Pierre Geborek, et al.
Arthritis Research & Therapy|December 15, 2015
Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA materialMitra Pikwer, Cecilia Orellana, Henrik Källberg, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Patients with regular physical activity before onset of rheumatoid arthritis present with milder diseaseMaria E C Sandberg, Sara Wedrén, Lars Klareskog, et al.
BMC Rheumatology|May 21, 2025
Association of matrix metalloproteinase 7 and the alpha-chain of fibrinogen at baseline with response to methotrexate at 3 months in patients with early rheumatoid arthritisKaren Hambardzumyan, Carl Hamsten, Lucía Lourido, et al.
Annals of the Rheumatic Diseases|December 15, 2010
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trialSaedis Saevarsdottir, Helena Wallin, Maria Seddighzadeh, et al.
BMJ Open|September 25, 2012
Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort studyAlf Kastbom, Lars Cöster, Lisbeth Arlestig, et al.
Pageof 11